Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to determine the incidence of osteoporosis in the
investigators' population of HIV-infected patients and to assess the efficacy and security of
zoledronic acid, whose efficacy in post-menopausal women with high fracture risk treatment
and in Paget's disease treatment has already been demonstrated.